Holen Sie sich die Stockscreener-App
61.07
3.09%
1.83
Handel nachbörslich:
60.86
-0.21
-0.34%
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers Goes Global, Named To Top Stocks List: Build Your Growth Stock Watchlist With These Just Updated Screens - Investor's Business Daily
Where Will Hims & Hers Stock Be In 10 Years? - Barchart.com
Hims & Hers Health Inc Stock: Navigating High Volatility and a Rich Valuation - Daily Chhattisgarh News
Bet on Winning DuPont Analysis & Pick 3 Top Stocks - Yahoo Finance
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth) - Barchart.com
Hims & Hers Health Annual Stockholders Meeting Results - TipRanks
Hims & Hers (HIMS) Stock Pauses After Explosive 134% Rally This Year, Highlighting Immense Growth - Daily Chhattisgarh News
These 2 Growth Stocks Are No-Brainer Buys Right Now - Yahoo Finance
VF Corp, MGM Resorts, PENN Entertainment, Hims & Hers Health, and Camping World Shares Are Soaring, What You Need To Know - Yahoo Finance
2 Reasons To Double Down On Hims & Hers Ahead Of August (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Stock Skyrockets Over 8%, Extending a Phenomenal 147% Annual Gain - Daily Chhattisgarh News
Where are the Opportunities in (HIMS) - news.stocktradersdaily.com
Hims & Hers: An Excellent Subscription Business - Seeking Alpha
The controversial rise of Franken-pills: Telehealth companies push to mix meds in a single pill - Sherwood News
Hims & Hers (HIMS) Stock Dips Amid Profit-Taking, But Yearly Gains Exceed a Massive 134% - Daily Chhattisgarh News
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hims & Hers Health and Sociedad Quimica y Minera de Chile have been highlighted as Zacks Bull and Bear of the Day - Zacks Investment Research
Where Will Hims & Hers Stock Be in 10 Years? - The Globe and Mail
Noteworthy Thursday Option Activity: PARR, VZ, HIMS - Nasdaq
Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth - Yahoo Finance
Hims & Hers (HIMS) Share Price Shows Explosive Growth, Surging Over 150% in a Year - Daily Chhattisgarh News
June 2025's Select Stocks That Could Be Trading Below Estimated Value - simplywall.st
Hims & Hers Health’s (HIMS) Equal Weight Rating Reaffirmed at Morgan Stanley - Defense World
3 Reasons We Love Hims & Hers Health (HIMS) - Yahoo Finance
HIMS Experiences Mixed Growth in App Downloads and Web Traffic | - GuruFocus
Hims & Hers (HIMS) Stock Soars, Capping a Year of Explosive Growth - Daily Chhattisgarh News
Hims & Hers Stock Falls After Eli Lilly Rules Out Telehealth Tie-Up: Citi Calls It Aggressive Stance, Retail Turns Bearish - MSN
Hims & Hers: The ZAVA Acquisition Catapults Growth In Europe's Weight-Loss Market - Seeking Alpha
Lilly Pacts Bar Telehealth Firms From Selling Copycat Zepbound - MSN
Needham Lifts PT on Hims & Hers Health (HIMS) Stock, Maintains Buy Rating - MSN
Hims & Hers Health (NYSE:HIMS) Shares Down 1.8% on Insider Selling - Defense World
Citi Keeps Hims & Hers (HIMS) Price Target, Maintains Sell Rating - MSN
HIMS Faces Uncertain Future with Potential Eli Lilly Partnership - GuruFocus
Is Hims & Hers Health a Smart Buy Right Now? - MSN
Lilly Pacts Prohibit Telehealth Sales of Copycat Zepbound - Bloomberg.com
Hims & Hers stock falls after Lilly rules out partnership - Investing.com Australia
Lilly (LLY) Pacts Bar Telehealth Firms From Selling Copycat Zepbound - Bloomberg.com
Hims & Hers says its weight-loss business can grow as US market changes - Reuters
Bought $40,000 of Hims & Hers (HIMS) Stock on a YOLO – Is it Time to Sell? - AOL.com
Hims & Hers Health's Strategy in the Evolving Weight-Loss Drug MarketNews and Statistics - IndexBox
Hims & Hers (NYSE: HIMS) Live: Complete Earnings Coverage - AOL.com
Bought $40,000 of Hims & Hers (HIMS) Stock on a YOLOIs it Time to Sell? - 24/7 Wall St.
Hims & Hers (HIMS) Stock Stays Flat After Volatile Session, Highlighting Massive Yearly Gains - Daily Chhattisgarh News
Analysis: Hims & Hers says its weight-loss business can grow as US market changes - Yahoo Finance
Why Hims & Hers Health (HIMS) Might be Well Poised for a Surge - Yahoo Finance
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey
Hims & Hers Health Unusual Options Activity - Nasdaq
Hims & Hers (HIMS) Stock Tumbles 10% in a Week, Pausing a Meteoric 160% Annual Rally - Daily Chhattisgarh News
Hims & Hers Health and AST SpaceMobile have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Hims & Hers Health, Inc. (NYSE:HIMS) Receives Consensus Rating of “Hold” from Analysts - Defense World
Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock? - The Motley Fool
Hims & Hers Health (NYSE:HIMS) Lowered to Hold Rating by Wall Street Zen - Defense World
This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare Space - The Motley Fool
Hims & Hers cuts 4% of staff after FDA ban on generic weight-loss drugs - Outsource Accelerator
Hims & Hers Health Inc (HIMS) Trading 6.2% Higher on Jun 6 - GuruFocus
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):